Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
07 07 2019
Historique:
received: 16 05 2019
revised: 26 06 2019
accepted: 03 07 2019
entrez: 10 7 2019
pubmed: 10 7 2019
medline: 1 5 2020
Statut: epublish

Résumé

Zinc finger protein 423 (ZNF423) is a transcriptional factor involved in the development and progression of cancers but has not yet been examined in cholangiocarcinoma (CCA), an oxidative stress-driven cancer of biliary epithelium. In this study, we hypothesized that oxidative stress mediated ZNF423 expression regulates its downstream genes resulting in CCA genesis. ZNF423 protein expression patterns and 8-oxodG (an oxidative stress marker) formation in CCA tissues were investigated using immunohistochemical analysis. The results showed that ZNF423 was overexpressed in CCA cells compared to normal bile duct cells adjacent of the tumor. Notably, ZNF423 expression was positively correlated with 8-oxodG formation. Moreover, ZNF423 expression in an immortalized cholangiocyte cell line (MMNK1) was increased by hydrogen peroxide-treatment, suggesting that oxidative stress induces ZNF423 expression. To investigate the roles of ZNF423 in CCA progression, ZNF423 mRNA was silenced using specific siRNA in CCA cell lines, KKU-100 and KKU-213. Silencing of ZNF423 significantly inhibits cell proliferation and invasion of both CCA cell lines. Taking all these results together, the present study denoted that

Identifiants

pubmed: 31284679
pii: biom9070263
doi: 10.3390/biom9070263
pmc: PMC6681239
pii:
doi:

Substances chimiques

Proteins 0
ornithine decarboxylase antizyme 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Cancer Imaging. 2014 Apr 22;14:14
pubmed: 25608662
J Biomed Biotechnol. 2012;2012:623019
pubmed: 22363173
J Recept Signal Transduct Res. 2014 Oct;34(5):378-85
pubmed: 24694005
Mol Cell Biol. 2013 Sep;33(17):3416-25
pubmed: 23798555
J Exp Med. 2013 Oct 21;210(11):2289-304
pubmed: 24081948
Parasitol Int. 2012 Mar;61(1):130-5
pubmed: 21704729
Oncotarget. 2017 Jun 27;8(47):81880-81891
pubmed: 29137230
J Biol Chem. 2010 Oct 1;285(40):30814-24
pubmed: 20547764
Mol Cell Oncol. 2014 Dec 23;1(3):e969655
pubmed: 27308357
J Neurosci. 1997 Jun 1;17(11):4159-69
pubmed: 9151733
J Hepatol. 2014 Jun;60(6):1268-89
pubmed: 24681130
Liver Int. 2009 Feb;29(2):291-8
pubmed: 18710428
Am J Physiol. 1995 May;268(5 Pt 1):L699-722
pubmed: 7762673
Oncol Lett. 2017 Mar;13(3):1325-1330
pubmed: 28454256
Nitric Oxide. 2004 Sep;11(2):175-83
pubmed: 15491850
J Hepatol. 2017 Feb;66(2):424-441
pubmed: 27686679
Free Radic Biol Med. 2012 Apr 15;52(8):1465-72
pubmed: 22377619
World J Gastroenterol. 2008 Feb 7;14(5):666-74
pubmed: 18205254
Int J Cancer. 2010 Dec 1;127(11):2576-87
pubmed: 20162672
Cell. 2000 Jan 21;100(2):229-40
pubmed: 10660046
Trends Biochem Sci. 1999 Jun;24(6):236-40
pubmed: 10366853
ASAIO J. 2007 Jan-Feb;53(1):17-22
pubmed: 17237644
Cancer Discov. 2013 Jul;3(7):812-25
pubmed: 23764426
Annu Rev Biochem. 1995;64:345-73
pubmed: 7574486
Proc Natl Acad Sci U S A. 1990 Feb;87(4):1620-4
pubmed: 2154753
Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):518-24
pubmed: 18349269
Diabetes. 2013 Nov;62(11):3727-35
pubmed: 23884886
Blood. 2009 May 7;113(19):4702-10
pubmed: 19234145
Horm Cancer. 2018 Dec;9(6):408-419
pubmed: 30284180
Cancer Cell. 2009 Apr 7;15(4):328-40
pubmed: 19345331
Oxid Med Cell Longev. 2017;2017:2597581
pubmed: 28770020
Tumour Biol. 2013 Apr;34(2):695-704
pubmed: 23188705
FEBS Lett. 1995 Aug 28;371(1):86-8
pubmed: 7664890
Transplantation. 2004 Feb 15;77(3):446-51
pubmed: 14966424
BMC Cancer. 2014 Aug 23;14:609
pubmed: 25151367
Redox Biol. 2018 Apr;14:637-644
pubmed: 29169115
Cancer Sci. 2011 Apr;102(4):815-27
pubmed: 21219539
Front Endocrinol (Lausanne). 2018 May 18;9:255
pubmed: 29867779
J Pathol. 2013 Oct;231(2):158-67
pubmed: 23878065
J Enzyme Inhib Med Chem. 2016;31(sup1):177-183
pubmed: 27028474
Cancer Sci. 2015 Nov;106(11):1515-23
pubmed: 26310932
J Neurochem. 2000 Feb;74(2):508-17
pubmed: 10646501
Int J Mol Sci. 2014 Dec 24;16(1):193-217
pubmed: 25547488
Genome Biol. 2003;4(6):216
pubmed: 12801404

Auteurs

Timpika Chaiprasert (T)

Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.

Napat Armartmuntree (N)

Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.

Anchalee Techasen (A)

Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.
Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.

Chadamas Sakonsinsiri (C)

Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.

Somchai Pinlaor (S)

Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.
Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.

Piti Ungarreevittaya (P)

Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.
Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.

Narong Khuntikeo (N)

Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.
Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.

Nisana Namwat (N)

Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.

Raynoo Thanan (R)

Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand. raynoo@kku.ac.th.
Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand. raynoo@kku.ac.th.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH